First Tracks Biotherapeutics (TRAXV) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 2 9 sessions, April 6, 2026 to April 17, 2026
- Largest daily move
- +27.4% close of April 8, 2026
Company Description
First Tracks Biotherapeutics (NASDAQ: TRAXV) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $782.2M.
TRAXV has declined 4.2% over the past week. The last closing price was $22.51.
This page collects what Stock Titan holds for TRAXV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
First Tracks Biotherapeutics (TRAXV) closed at $22.51 on April 17, 2026. Over the past week, the price has lost 4.2%.
TRAXV Metrics & Rankings
Price returns through April 17, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
First Tracks Biotherapeutics has filed 5 recent SEC filings, including 3 Form 4, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on May 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRAXV SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TRAXV Company Profile & Sector Positioning
First Tracks Biotherapeutics (TRAXV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.